Tuesday, November 21, 2017
Home Tags FDA

Tag: FDA

Humanigen, Inc. (OTCQB: HGEN) Declines 13.73% After Completing Human Bioavailability Study...

Humanigen, Inc. (OTCQB: HGEN) operates as biopharmaceutical company, which develops treatments for rare and untreated diseases. Shares of the pharmaceutical company dropped 13.73%, through...

Propanc Biopharma, Inc. (OTCQB: PPCB) Rallies 24% After Company Prepares FDA...

Propanc Biopharma, Inc. (OTCQB: PPCB) is engaged as a clinical stage pharmaceutical developer, which develops treatments for cancer and tumors. Shares of the cancer...

Guided Therapeutics, Inc. (OTCQB: GTHP) Jumps 20% After Re-Establishing Communications With...

Guided Therapeutics, Inc. (OTCQB: GTHP) is engaged within the research, development, commercialization, and distribution of its patented biophotonic technology, LuViva Advanced Cervical Scan. Shares...

Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) Rallies 24.83% After Receiving FDA Fast...

Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) operates as a biotechnology company, which focuses on developing treatments for fibrosis, inflammation, nerve damage, infection, and more. Shares...

Mateon Therapeutics, Inc. (OTCQX: MATN) Climbs 22.44% After Receiving FDA Fast...

Mateon Therapeutics, Inc. (OTCQX: MATN) operates as a biopharmaceutical company, which develops vascular disrupting agents (VDAs) for treating orphan oncology indications. Shares of the...

Propanc Biopharma, Inc. (OTCQB: PPCHD) Rallies 27% After Awaiting FDA Orphan...

Propanc Biopharma, Inc. (OTCQB: PPCHD) is an Australian-based biopharmaceutical company, which focuses on developing cancer treatments. Shares of the cancer biotech company are rallying...

Innovus Pharmaceuticals, Inc. (OTCQB: INNV) Gains 13.23% After Partnering With Hikma...

Innovus Pharmaceuticals, Inc. (OTCQB: INNV) is engaged as a specialty pharmaceutical and consumer goods company, which focuses on non-prescription treatments. Shares of the specialty...

Cell MedX Corp. (OTCQB: CMXC) Climbs 31.23% After Moving Manufacturing to...

Cell MedX Corp. (OTCQB: CMXC) is engaged in the research, development, and commercialization of treatments to alleviate complications associated with medical conditions. Shares of...

SIGA Technologies, Inc. (OTC Pink: SIGA) Increases 8.92% After Completing Enrollment...

SIGA Technologies, Inc. (OTC Pink: SIGA) specializes in the development, testing, and commercialization of unmet medical needs and bio-threats. Its flagship drug, TPOXX, is...

Relmada Therapeutics, Inc. (OTCQB: RLMD) Jumps 21% After Receiving Fast Track...

Relmada Therapeutics, Inc. (OTCQB: RLMD) is engaged in the research, development, and commercialization of treatments for central nervous system (CNS) diseases. Shares of the...